Skip to main content

Day: September 17, 2020

Methanex Announces Offering of Senior Unsecured Notes

Proceeds intended to be used for debt repayment, maintenance capital expenditures, working capital and other general corporate purposesVANCOUVER, British Columbia, Sept. 17, 2020 (GLOBE NEWSWIRE) — Methanex Corporation (TSX:MX) (NASDAQ:MEOH) announced today that it has launched an offering of senior unsecured notes. Methanex intends to use the net proceeds from the offering to repay or redeem our existing 5.25% unsecured notes due on March 1, 2022, of which US$250 million in aggregate principal amount is outstanding, and for maintenance capital expenditures, working capital or other general corporate purposes.J.P. Morgan Securities LLC, BMO Capital Markets Corp., BNP Paribas Securities Corp. and RBC Capital Markets, LLC are acting as the joint book-running managers of the offering. The notes will be offered via an underwritten public...

Continue reading

Holly Street Capital Ltd. Announces Letter of Intent for Qualifying Transaction With Southern Sky Resources Corp.

Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States.VANCOUVER, British Columbia, Sept. 17, 2020 (GLOBE NEWSWIRE) — Holly Street Capital Ltd. (TSX-V: HSC.P) (“Holly”), a capital pool company listed on the TSX Venture Exchange (the “Exchange”), is pleased to announce that it has entered into a binding letter of intent (the “Letter of Intent”) dated September 10, 2020 with Southern Sky Resources Corp. (“Southern Sky”) in respect of a proposed business combination (the “Proposed Transaction”). It is anticipated that the Proposed Transaction will constitute the “Qualifying Transaction” of Holly in accordance with Policy 2.4 – Capital Pool Companies of the Exchange.About Southern SkySouthern Sky is a private...

Continue reading

Management´s buy of shares – Reporting of transactions in accordance with Article 19 of the Market Abuse Regulation

Company announcement no 06 2020/21Allerød, 17 September 2020Management´s buy of shares – Reporting of transactions in accordance with Article 19 of the Market Abuse RegulationMatas has according to the EU market abuse regulation art. 19 received the below reports from members of the board of directors, management and their related parties’ transactions in Matas shares:For further informationAnders T. Skole-SørensenCFOTel.: +45 48 16 55 55Attachment06 2020-21 – Management´s buy of shares – Reporting of transactions UK

Continue reading

Ledelsens køb af aktier – Indberetning om transaktioner i henhold til Markedsmisbrugsforordningens artikel 19

Selskabsmeddelelse 06 2020/21Allerød den 17. september 2020Ledelsens køb af aktier – Indberetning om transaktioner i henhold til Markedsmisbrugsforordningens artikel 19Matas har i henhold til markedsmisbrugsforordningens art. 19 modtaget nedenstående indberetninger fra bestyrelsesmedlemmer og ledende medarbejdere og disses nærtståendes transaktioner med Matas aktier:  For yderligere informationAnders T. Skole-SørensenCFOTlf.: + 45 48 16 55 55Vedhæftet fil06 2020-21 – Ledelsens køb af aktier – Indberetning om transaktioner DK

Continue reading

ERYTECH ospiterà il giorno 22 settembre 2020 la teleconferenza e il business update relativi al secondo trimestre 2020

LIONE, Francia, Sept. 17, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), un’azienda biofarmaceutica in fase clinica che sviluppa terapie innovative incapsulando sostanze farmacologiche all’interno dei globuli rossi, ha annunciato oggi che ospiterà la teleconferenza e il webcast del secondo trimestre 2020 di martedì 22 settembre 2020, alle ore 14:30 CEST/8:30 EST per discutere i principali dati economici.La teleconferenza sarà accessibile attraverso i numeri di teleconferenza riportati di seguito, seguiti dall’ID# della conferenza: 8585556#      È possibile seguire il webcast online tramite il link: https://edge.media-server.com/mmc/p/ypvwj59iPer 7 giorni sarà disponibile una registrazione chiamando il numero+ 1 855 859 2056, ID della conferenza: 8585556#.Sul sito web di ERYTECH sarà disponibile...

Continue reading

ERYTECH führt am 22. September 2020 eine Telefonkonferenz zum zweiten Quartal 2020 und ein Unternehmens-Update durch

LYON, Frankreich, Sept. 17, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), ein biopharmazeutisches Unternehmen im Bereich der klinischen Forschung, das innovative Therapien entwickelt, bei denen Arzneimittelwirkstoffe in roten Blutkörperchen eingekapselt werden, kündigte heute an, dass am Dienstag, dem 22. September 2020, um 14:30 Uhr MEZ/8:30 Uhr EST eine Telefonkonferenz und ein Webcast zum zweiten Quartal 2020 veranstaltet wird, um operative Highlights zu diskutieren.Die Einwahl erfolgt über die folgenden Telefonkonferenznummern, gefolgt von der Konferenz-ID: 8585556#      Der Webcast kann online live über folgenden Link verfolgt werden: https://edge.media-server.com/mmc/p/ypvwj59iEine Aufzeichnung der Konferenz ist anschließend 7 Tage lang unter der folgenden Einwahlnummer abrufbar: + 1 855 859...

Continue reading

Hemp, Inc. CEO Bruce Perlowin Discusses Proposed Hemp Regulations With Fox Business

Las Vegas, NV, Sept. 17, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Hemp, Inc. (OTC PINK: HEMP), a global leader in the industrial hemp industry with an 85,000 square-foot multipurpose industrial hemp processing facility in Spring Hope, North Carolina; a 500-acre hemp growing Veteran Village Kins Community in Golden Valley, Arizona; two model “Small Family Hemp Farms” in North Carolina and Arizona; a hemp pre-roll blending manufacturing facility in Las Vegas, NV; a 5,000 square-foot retail store (The King of Hemp Store™) in Kingman, Arizona; and recently surpassed over $2 million in sales of their pre-98 OG Bubba Kush buds, has announced that its CEO Bruce Perlowin has been featured in a Fox Business article.The article, “USDA reopens comment period on hemp regulations as lawmakers, growers worry rules could stunt budding...

Continue reading

Kintavar Announces That Exploration Activities Have Commenced by IAMGOLD on the Anik Gold Project

MONTRÉAL, Sept. 17, 2020 (GLOBE NEWSWIRE) — Kintavar Exploration Inc. (the “Corporation” or “Kintavar”) (TSX-V: KTR) (FRANKFURT: 58V), is very pleased to announce that its partner IAMGOLD Corporation (“IAMGOLD”) has begun field exploration work on the Anik gold project in the Chibougamau region of Quebec. The field work will consist of additional till surveys, examination and characterisation of the core from Kintavar’s previous drilling programs and outcrops exposed in the various trenches on the property. Data compilation of the various geophysical and geochemical programs is continuing which will help the exploration team with target identification and planning, leading to the drill program that is expected to take place during this upcoming winter.“IAMGOLD’s technical team are seasoned professionals that understand the region’s...

Continue reading

Kintavar annonce le début des travaux d’exploration sur la propriété aurifère Anik par son partenaire IAMGOLD

MONTRÉAL, 17 sept. 2020 (GLOBE NEWSWIRE) — Kintavar Exploration Inc. (la «Société» ou «Kintavar») (TSX-V: KTR) (FRANCFORT: 58V), est très heureuse d’annoncer que son partenaire IAMGOLD Corporation («IAMGOLD») a débuté les travaux d’exploration sur le projet aurifère Anik dans la région de Chibougamau au Québec. Les travaux sur le terrain consisteront en levés supplémentaires de till et en révision et caractérisation des forages, des affleurements et des tranchées qui ont été réalisés ou mis à jour par Kintavar sur la propriété. La compilation des données géophysiques et géochimiques des divers levés se poursuit et permettra à l’équipe d’exploration d’identifier et de planifier les cibles de forages dont la réalisation est prévue à l’hiver prochain.«L’équipe technique d’IAMGOLD est composée de professionnels...

Continue reading

InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strategy Officer

Thomas Taapken, Ph.D. appointed Chief Financial OfficerJordan Zwick promoted to Chief Strategy OfficerJENA, Germany, Sept. 17, 2020 (GLOBE NEWSWIRE) — InflaRx (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, today announced two management appointments. Effective October 1, 2020, Thomas Taapken, Ph.D. will join InflaRx as Chief Financial Officer. Jordan Zwick has been promoted to Chief Strategy Officer, effective immediately.Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, said: “I am delighted to welcome Thomas to InflaRx. He brings extensive senior management expertise in the public biopharmaceutical sector, including at companies with marketed products, and is an ideal fit as we advance our late-stage clinical development...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.